Effects of dynorphins on body temperature of rats

Effects of dynorphins on body temperature of rats

Pharmacoiogical Research Commun/cations, Voi. 20, No. 7, 1988 603 EFFECTS OF DYNORPHINS ON BODYTEMPERATURE OF RATS E. Cavicchini, S. Candeletti and ...

100KB Sizes 0 Downloads 82 Views

Pharmacoiogical Research Commun/cations, Voi. 20, No. 7, 1988

603

EFFECTS OF DYNORPHINS ON BODYTEMPERATURE OF RATS E. Cavicchini, S. Candeletti and S. Ferri Institute of Pharmacology. University of Bologna, Irnerio 48, 40126 Bologna ~.~j words

no~ins

-

Bodytemperature

-

Opioid antagonists

-

Verapamil

After the isolation and identification of Dynorphin A (Dyn A) (Goldstein et al.

1979), other

related

to

sequences endowed with opioid

Dyn A,

activity,

have been found to derive from the

structurally-

same precursor,

prodynorphin. The purpose of the present study was to characterize the effects of Dyn A and other prodynorphin-related peptides, namely Dyn B and Dyn A-(1-32), on thermoregulation.

In addition, the involvement of Ca++ in their action was

investigated. Drugs were intracerebroventricularly ( i . c . v . ) administered in unrestrained ninsula,

male rats kept at room temperature (22~C).

San Carlos, CA) and other chemicals injected in a volume of 5 ~ I .

Rectal temperature values were taken 20 min before the tions

Peptides (Pe-

and, after, at

the intervals indicated in

i.c.v,

Figure I.

administraResults were

expressed as mean ~ SEM. Comparisons were made by Student's t - t e s t . (5

Dyn A

and 10 nmol) induced a decrease in body temperature that was maximal

min after within

administration

ana then gradually returned to

120 m i n ; Dyn A-(1-32) (2.5 and 5 nmol) caused a

controi

nmol),

values

longer a c t i v i t y

whereas Dyn B (up to 20 nmol) did not induce any significant The hypothermic effect was prevented by i . c . v ,

30

hypothermia.

administered MR 1452 (30

a preferential antagonist of the ( opioid

receptor.

Naloxone, a

preferential ~ receptor antagonist and naltrexone, its long lasting'analog, up to doses of 100 nmol,as well as MR 1453, (+)-enantiomer of antagonist MR 1452 and devoid of opioid receptors binding properties, the hypothermic effect. mia

did not antagonize

A significant reduction of Dyn A-induced hypother-

(5 pmo]) was elicited by the calcium channel blocker verapamil i.c.v.

administered (10ug). Results of the present investigation showed that i.c.v,

administered Dyn A

and Dyn A-(1-32) induce a clear-cut hypothermia in rats.

0031-6989/881070603-2/$03.00/0

The lack

of

a

© 1988 The Italian Pharmacological Society

Pharmacological Research Communications, Vol. 20, No. 7, 1988

604

1

;

~......L.-L

I

'"

!

.

; ;s so 45 e'o

P

'

io

A

1~0 TIME

Fig. 1. (C) Dyn (A) ( e ) (B) ( e ) (C) ( e ) ~p <

.~

~

'

'"'

; ¢5 ~0 4'5 ~0 AFTER

t.¢.V.

.L.

B

}

.0

INJECTION

1~0

,

,

|

C

f

I

0 15 30 4~ 60

I

so

I

1~0

(mtn)

Effect of the i.c.v, administration of (A) Dyn A, (B) Dyn A-(I-32), B on rectal temperature, in the rat. saline; ( 0 ) Dyn A 2.5 nmol; (BII) Dyn A 5 nmol;(A) Dyn A 10 nmol. saline ; ( 0 ) Dyn A-(1-32) 2.5 nmol; (M) Dyn A-(1-32) 5 nmol; sa|ine; (Z~) Dyn B 10 nmol; (I"I) Dyn B 20 nmoI. 0.05 vs control values.

significant

blockade by naloxone and naltrexone and the finding

that

MR

1452 significantly antagonized the dynorphin-induced hypothermia, indicated a ~ receptor involvement in phenomena elicited by dynorphins. The different efficacy of Dyn A, to

the

Dyn A-(1-32) and Dyn B could be ascribed

different a f f i n i t y of these fragments for the ~ opioid

receptor,

already reported by James et al. (1984), "in vitro". The longer activity of Dyn A-(I-32)

could also

comparison to reduction involvement

of

be related to

a less

Dyn A (Spampinato and Candeletti,

rapid

degradation

1985). Fina]ly

Dyn A-induced hypothermia by verapamil suggested

of Ca++in the peptide effect and supported the

existence

in the an of

relationships between Ca++movements and opioids (Ross et al., 1979). REFERENCES GOLDSTEIN. A., TACHIBANA, S., LOWNEY, L . I . , HUNKAPILLER,M., HOOD, L. (1979), Proc. Natl. Acad. Sci. USA, 76: 6666-66?0. JAMES, I.F., FISCHLI,W. and GOLDSTEIN, A. (1984), J. Pharmacol. Exp. Ther., 228~ 88-93. ROSS, D.H. and CANDENAS, H.L. (1979),Adv. Biochem. Psychopharmacol., 20: 301-336. SPAMPINATO,S. and CANDELETTI, $. (1985),European J. Pharmacol., 110: 21-30.